We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

71 hedge funds and large institutions have $285M invested in Korro Bio in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

57% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 14

11% more funds holding

Funds holding: 64 → 71 (+7)

0.79% more ownership

Funds ownership: 91% → 91.8% (+0.79%)

0% less capital invested

Capital invested by funds: $286M → $285M (-$416K)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
71
Holders Change
+7
Holders Change %
+10.94%
% of All Funds
1.02%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
15
Increased
22
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SSA
Schonfeld Strategic Advisors
New York
+$4.31M
2
DTC
Deep Track Capital
Connecticut
+$3.34M
3
BlackRock
BlackRock
New York
+$1.83M
4
Northern Trust
Northern Trust
Illinois
+$1.79M
5
ACM
ADAR1 Capital Management
Texas
+$1.78M

Top Sellers

1
AG
Artal Group
Luxembourg
-$14M
2
EAM
Eventide Asset Management
Massachusetts
-$5.81M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.51M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.32M
5
Verition Fund Management
Verition Fund Management
Connecticut
-$1.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Hudson Bay Capital Management
26
Hudson Bay Capital Management
Connecticut
$1M +$1.26M +30,000 New
Morgan Stanley
27
Morgan Stanley
New York
$781K +$435K +10,334 +79%
Charles Schwab
28
Charles Schwab
California
$587K – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$480K -$202K -4,795 -25%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$436K +$549K +13,052 New
Goldman Sachs
31
Goldman Sachs
New York
$428K +$161K +3,823 +43%
JP Morgan Chase
32
JP Morgan Chase
New York
$414K +$412K +9,782 +375%
William Blair & Company
33
William Blair & Company
Illinois
$408K +$513K +12,200 New
N
34
Nuveen
North Carolina
$373K – – –
UBS Group
35
UBS Group
Switzerland
$325K +$224K +5,317 +120%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$298K +$28.8K +684 +8%
HF
37
HRT Financial
New York
$221K -$1.09M -25,882 -80%
Bank of America
38
Bank of America
North Carolina
$216K +$64.6K +1,536 +31%
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$164K +$188K +4,470 +1,018%
Citigroup
40
Citigroup
New York
$148K +$129K +3,074 +226%
MIM
41
MetLife Investment Management
New Jersey
$122K +$86.3K +2,050 +129%
Mirae Asset Global ETFs Holdings
42
Mirae Asset Global ETFs Holdings
Hong Kong
$112K +$141K +3,350 New
CF
43
Corebridge Financial
Texas
$109K -$842 -20 -0.6%
Deutsche Bank
44
Deutsche Bank
Germany
$106K +$134K +3,175 New
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$100K – – –
VI
46
Vestcor Inc
New Brunswick, Canada
$100K +$126K +3,000 New
BBHC
47
Brown Brothers Harriman & Co
New York
$95.4K +$85.9K +2,041 +251%
Wells Fargo
48
Wells Fargo
California
$85.6K +$2.86K +68 +3%
A
49
AlphaQuest
New York
$59.4K +$47.3K +1,124 +172%
NSIM
50
North Star Investment Management
Illinois
$33.4K -$42.1K -1,000 -50%
1
2
3 4

KRRO Hedge Fund Activity: Q3 2024 in Review

71 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2024, worth a combined $285M — down 0.15% from $286M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new KRRO positions and 8 closed out — a net gain of 7 holders — while 22 added to existing stakes and 14 trimmed.

The largest buyer was Schonfeld Strategic Advisors, adding an estimated $4.31M. The largest seller was Artal Group, exiting entirely with an estimated $14M sold.

  • 71 institutional investors held Korro Bio (KRRO) as of Q3 2024, up from 64 in Q2 2024.
  • Funds reported $285M of Korro Bio stock for Q3 2024, down 0.15% quarter-over-quarter.
  • 15 funds opened new Korro Bio positions in Q3 2024 and 8 closed out, a net change of +7 holders.
  • The largest Korro Bio buyer in Q3 2024 was Schonfeld Strategic Advisors, an estimated $4.31M added.
  • The largest Korro Bio seller in Q3 2024 was Artal Group, an estimated $14M sold.

Based on aggregated 13F filings for Q3 2024.